# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001069530-22-000033
Filing Date
2022-08-04
Accepted
2022-08-04 16:01:03
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | sava-20220630x10q.htm iXBRL | 10-Q | 2241683
2 | EX-10.1 | sava-20220630xex10_1.htm | EX-10.1 | 4632
3 | EX-31.1 | sava-20220630xex31_1.htm | EX-31.1 | 25547
4 | EX-31.2 | sava-20220630xex31_2.htm | EX-31.2 | 25246
5 | EX-32.1 | sava-20220630xex32_1.htm | EX-32.1 | 20428
6 | GRAPHIC | sava-20220630x10qg001.jpg | GRAPHIC | 28862
7 | GRAPHIC | sava-20220630x10qg002.jpg | GRAPHIC | 30381
8 | GRAPHIC | sava-20220630x10qg003.jpg | GRAPHIC | 46460
9 | GRAPHIC | sava-20220630x10qg004.jpg | GRAPHIC | 31851
10 | GRAPHIC | sava-20220630x10qg005.jpg | GRAPHIC | 93477
| Complete submission text file | 0001069530-22-000033.txt |  | 7490737

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
11 | EX-101.SCH | sava-20220630.xsd | EX-101.SCH | 33070
12 | EX-101.CAL | sava-20220630_cal.xml | EX-101.CAL | 43114
13 | EX-101.DEF | sava-20220630_def.xml | EX-101.DEF | 118884
14 | EX-101.LAB | sava-20220630_lab.xml | EX-101.LAB | 253951
15 | EX-101.PRE | sava-20220630_pre.xml | EX-101.PRE | 247261
61 | EXTRACTED XBRL INSTANCE DOCUMENT | sava-20220630x10q_htm.xml | XML | 1298052

Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29959 | Film No.: 221136361
SIC: 2834 Pharmaceutical Preparations